Screener
MetLife MET Contractholder-directed equity securities and fair value option securities, at estimated fair value
Contractholder-directed equity securities and fair value option securities, at estimated fair value at other companies
Other financials
Where this comes from
Reported directly by MetLife in its filing.
Tagged under the XBRL concept met:ContractholderDirectedEquitySecuritiesAndFairValueOptionSecuritiesAtEstimatedFairValue.
The source filing: MetLife’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:32 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001099219-26-000050
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Investments: | ||
| Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $224 and $249, respectively); and amortized cost: $347,781 and $337,201, respectively | $322,183 | $315,931 |
| Equity securities, at estimated fair value | 932 | 858 |
| Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes $1,985 and $1,751, respectively, relating to variable interest entities) | 14,809 | 13,959 |
| Mortgage loans (net of allowance for credit loss of $1,358 and $1,193, respectively; includes $0 and $35, respectively, of mortgage loans held-for-sale) | 82,856 | 84,593 |
| Policy loans | 8,226 | 8,547 |
| Real estate and real estate joint ventures (includes $377 and $378, respectively, under the fair value option; $178 and $132, respectively, of real estate held-for-sale; $431 and $302, respectively, relating to variable interest entities) | 13,065 | 13,440 |
| Other limited partnership interests | 14,801 | 14,917 |
Item 1. Financial Statements
FAQ
- What is MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value?
- MetLife (MET) reported contractholder-directed equity securities and fair value option securities, at estimated fair value of $14.81B in Q2 2026.
- How has MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value changed year-over-year?
- MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value increased by 26.6% year-over-year, from $11.69B to $14.81B.
- What is the long-term trend for MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value?
- Over 5 years (2020 to 2025), MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value has grown at a 0.9% compound annual growth rate (CAGR), from $13.32B to $13.96B.
- What does contractholder-directed equity securities and fair value option securities, at estimated fair value mean?
- Contractholder-directed equity securities and fair value option securities, at estimated fair value as reported by MetLife, Inc..
Ask your AI about MetLife's contractholder-directed equity securities and fair value option securities, at estimated fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude